Anugerah 88 Logo
$518.39+0.64|(+0.12%)
52W H: 769.9852W L: 500.61Beta: 1.56

About IDEXX Laboratories Inc

Frequently Asked Questions

What is the 52-week range for IDXX?

The 52-week high is $769.98 and the 52-week low is $500.61.

What is the P/E ratio for IDXX?

The Price to Earnings (P/E) ratio is 36.03.

What is the dividend yield for IDXX?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is 71.96%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is 25.03%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 33.65.

Analyst Recommendation Trends

Wall Street analyst consensus for IDXX over the last few months:

2026-09-01
Buy: 7
S.Buy: 7
Hold: 8
Sell: 0
2026-08-01
Buy: 7
S.Buy: 7
Hold: 8
Sell: 0
2026-07-01
Buy: 7
S.Buy: 7
Hold: 8
Sell: 0
2026-06-01
Buy: 7
S.Buy: 7
Hold: 8
Sell: 0

Latest IDXX News

IDEXX Laboratories to Release 2026 Third Quarter Financial Results

WESTBROOK, Maine, October 01, 2026--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 third quarter financial results for Monday, November 2, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.

Yahoo10/1/2026

Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories

Chicago Pacific Founders ("CPF") today announced the exit of its investment in CoVetAI Inc. ("CoVet") following the company's acquisition by IDEXX Laboratories, Inc. (NASDAQ: IDXX). Financial terms were not disclosed.

Yahoo9/30/2026

Companion Animal Diagnostic Market Forecasts Growth from $3.56B (2026) to $5.40B by 2031, Profiling IDEXX Laboratories & Zoetis

The companion animal diagnostics market is projected to grow from USD 3.56 billion in 2026 to USD 5.40 billion by 2031, registering an 8.7% CAGR. Growth is driven by rising pet healthcare spending, preventive care, chronic and infectious diseases, and advances in AI, molecular diagnostics, point-of-care testing and automated analyzers. Molecular diagnostics will record the fastest growth, while consumables remain the leading product segment. Asia Pacific is expected to be the fastest-growing reg

Yahoo9/24/2026

Should You Continue to Hold IDXX Stock in Your Portfolio?

IDEXX's CAG growth, expanding software adoption and global gains face headwinds from FX and weaker U.S. vet visits.

Yahoo9/23/2026

IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets

IDEXX Laboratories (NASDAQ:IDXX) executives highlighted the company’s diagnostic innovation pipeline, recurring-revenue growth and commercial investments during the Morgan Stanley Global Healthcare Conference, while reaffirming confidence in its long-term growth framework despite continued pressure

Yahoo9/20/2026

IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference

IDEXX Laboratories (NASDAQ:IDXX) executives reiterated the company’s long-term growth framework at the Morgan Stanley Global Healthcare Conference, citing demand for veterinary diagnostics, product innovation, commercial investments and recurring-revenue economics as key drivers. Chief Executive Of

Yahoo9/20/2026

IDEXX (IDXX) Bets an AI Scribe Can Sell More Pet Diagnostics

On September 16, IDEXX Laboratories (NASDAQ:IDXX) announced it had bought CoVetAI, a fast-growing veterinary software company whose tool listens during appointments and organizes what gets said and done. It sounds like a productivity gadget. But IDEXX is pitching it as a way to put the right patient details in front of a vet at the […]

Yahoo9/19/2026

IDEXX (IDXX) Stock Trades Below Fair Value Following Its 26% Slide

IDEXX Laboratories has seen a mixed share price story in recent years, and the question now is whether its current US$506.48 level lines up with the cash flows the business may generate over time. Recent price pressure and fresh AI-driven software ambitions are pulling investor attention back to a simple issue: what are those cash flows worth today? Over the past 5 years the stock has delivered a decline of 25.8%, which puts the focus squarely on whether the cash flow outlook still supports...

Yahoo9/18/2026

IDEXX Laboratories (IDXX) Could Be 29% Below Fair Value As Diagnostics Growth Stays In Focus

IDEXX Laboratories (IDXX) drew fresh attention after expanding its Faecal Dx antigen testing platform in the United Kingdom to cover taeniid tapeworms, including Taenia and Echinococcus species, during routine veterinary visits. Recent moves by IDEXX Laboratories, including the Faecal Dx expansion and the CoVetAI acquisition, come as the share price sits at US$506.48. The year-to-date share price return is down 24.4%, but the 3-year total shareholder return remains positive at 15.46%,...

Yahoo9/17/2026

IDEXX Stock Gains Following the Acquisition of CoVet

IDXX shares rise 0.6% after the company acquires CoVet, expanding its AI-native software capabilities to improve veterinary workflows, diagnostics and practice performance.

Yahoo9/17/2026

Is IDEXX’s Expanded Zoonosis Testing Menu Altering The Investment Case For IDEXX Laboratories (IDXX)?

IDEXX Laboratories recently expanded its Faecal Dx antigen testing platform in the United Kingdom to include taeniid tapeworm detection, broadening routine intestinal parasite screening to seven clinically relevant parasite groups and triggering automatic, complimentary Echinococcus RealPCR follow-up tests for positive cases. This expansion deepens the clinical scope and perceived value of Faecal Dx, which has already been used in more than 50 million tests globally since 2012, potentially...

Yahoo9/17/2026

IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection

WESTBROOK, Maine, September 17, 2026--IDEXX expands Faecal Dx™ antigen testing platform in the United Kingdom with taeniid tapeworm detection for broader intestinal parasite screening.

Yahoo9/17/2026

IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence

WESTBROOK, Maine, September 16, 2026--IDEXX announces acquisition of CoVetAI to advance veterinary workflow intelligence.

Yahoo9/16/2026

IDEXX Laboratories, Inc. (IDXX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

IDEXX Laboratories, Inc. (IDXX) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 10:45 AM EDTCompany ParticipantsMichael Erickson...

SeekingAlpha9/14/2026

Tracking Ron Baron's BAMCO Portfolio - Q2 2026 Update

Ron Baron’s BAMCO 13F hits $66.6B, led by SpaceX, Tesla & MSCI.

SeekingAlpha9/13/2026

Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For?

If you hold Pfizer (PFE) or Zoetis (ZTS), you hold the same idea: a branded medicine becomes a standard of care and keeps earning for years, in people or in animals. That is where it stops. Pfizer is buying replacements for older drugs losing exclusivity. Zoetis is cutting its effective price to keep the franchises it has. Same bet, two opposite defenses.

Yahoo9/10/2026

Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock

Kingsley exercised options at $114.17 per share before immediately selling at $532.08, capturing a significant gain. His direct stake remains at 9,568 shares worth $5.12 million.

Yahoo9/10/2026

Engaging In Options Activity, Lawrence D Kingsley Exercises Options Valued At $873K In IDEXX Laboratories

In a new SEC filing on September 9, it was revealed that Kingsley, Board Member at IDEXX Laboratories (NASDAQ:IDXX), executed a significant exercise of company stock options. What Happened: Disclosed in a Form 4 filing

Benzinga9/10/2026

Baron Partners Fund Q2 2026 Contributors And Detractors

Top contributors include Space Exploration Technologies, Tesla, Red Rock Resorts, Hyatt Hotels and Birkenstock Holding. Read more here.

SeekingAlpha9/10/2026

Is IDEXX Laboratories Stock Underperforming the Dow?

Despite trailing the Dow over the past year, IDEXX still has Wall Street on its side, with analysts maintaining a cautiously optimistic view on its future prospects.

Yahoo9/10/2026

Baron Focused Growth Fund Q2 2026 Portfolio Update

The Fund's weightings are significantly different than those of the Benchmark, which explains why the Fund has such high active share of almost 100%. Read more here.

SeekingAlpha9/3/2026

Related Stocks (Peers)

Companies operating in similar sectors to IDXX:

ISRGSYKBSXEWBDXIDXXDXCMRMDGEHCZBHPENABT

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-04Kingsley Lawrence D-2,203--
2026-09-04Kingsley Lawrence D-2,203$532.0826$1,172,178
2026-09-04Kingsley Lawrence D+2,203$114.17$251,517
2026-08-20Emerson Andrew-265--
2026-08-20Emerson Andrew-86--
2026-08-20Emerson Andrew+265$178.26$47,239
2026-07-30HOOLEY JOSEPH L+49$558.8$27,381
2026-06-01FENNELL GEORGE-639--
2026-06-01FENNELL GEORGE-284$566.79$160,968
2026-06-01FENNELL GEORGE+639--
2026-05-12Peacock Karen+234--
2026-05-12Peacock Karen+525--
2026-05-12SAMAD SAM+234--
2026-05-12SAMAD SAM+525--
2026-05-12Britt Irene Chang+234--
2026-05-12Britt Irene Chang+525--
2026-05-12Vandebroek Sophie V.+234--
2026-05-12Vandebroek Sophie V.+525--
2026-05-12Claflin Bruce L.+234--
2026-05-12Claflin Bruce L.+525--
2026-05-12Kingsley Lawrence D+75--
2026-05-12Kingsley Lawrence D+234--
2026-05-12Kingsley Lawrence D+168--
2026-05-12Kingsley Lawrence D+525--
2026-05-12ESSIG STUART+234--
2026-05-12ESSIG STUART+525--
2026-05-12HOOLEY JOSEPH L+234--
2026-05-12HOOLEY JOSEPH L+525--
2026-05-12JUNIUS DANIEL M+234--
2026-05-12JUNIUS DANIEL M+525--
2026-05-07Peacock Karen-101--
2026-05-07Peacock Karen+101--
2026-05-07Vandebroek Sophie V.-257--
2026-05-07Vandebroek Sophie V.+257--
2026-05-07Kingsley Lawrence D-82--
2026-05-07Kingsley Lawrence D-257--
2026-05-07Kingsley Lawrence D+82--
2026-05-07Kingsley Lawrence D+257--
2026-05-07HOOLEY JOSEPH L-158--
2026-05-07HOOLEY JOSEPH L+158--
2026-05-07SZOSTAK M ANNE-257--
2026-05-07SZOSTAK M ANNE+257--
2026-05-07JUNIUS DANIEL M-257--
2026-05-07JUNIUS DANIEL M+257--
2026-04-30HOOLEY JOSEPH L+43$560.8$24,114
2026-03-03Hunt Nimrata-1,758$634.5718$1,115,577
2026-03-03Underberg Sharon E.-197--
2026-03-03Underberg Sharon E.+197$505.53$99,589
2026-02-27MAZELSKY JONATHAN JAY-197--
2026-02-27MAZELSKY JONATHAN JAY+197$505.53$99,589
2026-02-26MAZELSKY JONATHAN JAY-23,326--
2026-02-26MAZELSKY JONATHAN JAY-2,589$663.0439$1,716,621
2026-02-26MAZELSKY JONATHAN JAY-1,000$662.1567$662,157
2026-02-26MAZELSKY JONATHAN JAY-1,200$661.0976$793,317
2026-02-26MAZELSKY JONATHAN JAY-2,859$659.7495$1,886,224
2026-02-26MAZELSKY JONATHAN JAY-3,660$658.9166$2,411,635
2026-02-26MAZELSKY JONATHAN JAY-2,860$657.8438$1,881,433
2026-02-26MAZELSKY JONATHAN JAY-1,343$656.8451$882,143
2026-02-26MAZELSKY JONATHAN JAY-1,488$655.8498$975,905
2026-02-26MAZELSKY JONATHAN JAY-1,111$654.6294$727,293
2026-02-26MAZELSKY JONATHAN JAY-1,171$653.6763$765,455
2026-02-26MAZELSKY JONATHAN JAY-1,669$652.4945$1,089,013
2026-02-26MAZELSKY JONATHAN JAY-1,095$651.4866$713,378
2026-02-26MAZELSKY JONATHAN JAY-1,281$650.6695$833,508
2026-02-26MAZELSKY JONATHAN JAY+23,326$141.6$3,302,962
2026-02-26Hunt Nimrata-2,693$661.5413$1,781,531
2026-02-19Erickson Michael G-197--
2026-02-19Erickson Michael G-183--
2026-02-19Erickson Michael G-483--
2026-02-19Erickson Michael G-817--
2026-02-19Erickson Michael G-719--
2026-02-19Erickson Michael G+197$505.53$99,589
2026-02-19Erickson Michael G+183$544.08$99,567
2026-02-19Erickson Michael G+483$206.94$99,952
2026-02-19Erickson Michael G+817$178.26$145,638
2026-02-19Erickson Michael G+719$141.6$101,810
2026-02-17Erickson Michael G-4,180--
2026-02-17Erickson Michael G-1,191--
2026-02-17Erickson Michael G-40$629.8625$25,195
2026-02-17Erickson Michael G-689$629.0906$433,443
2026-02-17Erickson Michael G-2,694$628.2208$1,692,427
2026-02-17Erickson Michael G-1,288$626.2564$806,618
2026-02-17Erickson Michael G-204$625.2423$127,549
2026-02-17Erickson Michael G-456$623.7582$284,434
2026-02-17Erickson Michael G+4,180$178.26$745,127
2026-02-17Erickson Michael G+1,191$141.6$168,646
2026-02-17Vandebroek Sophie V.-945--
2026-02-17Vandebroek Sophie V.-519$628.56$326,223
2026-02-17Vandebroek Sophie V.-945$628.646$594,070
2026-02-17Vandebroek Sophie V.+945$333.9$315,536
2026-02-14Emerson Andrew-194--
2026-02-14Emerson Andrew-42--
2026-02-14Emerson Andrew-94--
2026-02-14Emerson Andrew-61--
2026-02-14Emerson Andrew-123$629.35$77,410
2026-02-14Emerson Andrew+65--
2026-02-14Emerson Andrew+194--
2026-02-14Emerson Andrew+42--
2026-02-14Emerson Andrew+94--
2026-02-14Emerson Andrew+61--
2026-02-14Erickson Michael G-1,508--
2026-02-14Erickson Michael G-184--
2026-02-14Erickson Michael G-301--
2026-02-14Erickson Michael G-94--
2026-02-14Erickson Michael G-92--
2026-02-14Erickson Michael G-184--
2026-02-14Erickson Michael G-974$629.35$612,987
2026-02-14Erickson Michael G+184--
2026-02-14Erickson Michael G+1,508--
2026-02-14Erickson Michael G+184--
2026-02-14Erickson Michael G+301--
2026-02-14Erickson Michael G+94--
2026-02-14Erickson Michael G+92--
2026-02-14Schreck Michael-1,005--
2026-02-14Schreck Michael-367--
2026-02-14Schreck Michael-301--
2026-02-14Schreck Michael-169--
2026-02-14Schreck Michael-117--
2026-02-14Schreck Michael-876$629.35$551,311
2026-02-14Schreck Michael+1,005--
2026-02-14Schreck Michael+367--
2026-02-14Schreck Michael+301--
2026-02-14Schreck Michael+169--
2026-02-14Schreck Michael+117--
2026-02-14Johnson Michael Perkins-218--
2026-02-14Johnson Michael Perkins-179--
2026-02-14Johnson Michael Perkins-176--
2026-02-14Johnson Michael Perkins-178$629.35$112,024
2026-02-14Johnson Michael Perkins+218--
2026-02-14Johnson Michael Perkins+179--
2026-02-14Johnson Michael Perkins+176--
2026-02-14Hunt Nimrata-1,508--
2026-02-14Hunt Nimrata-367--
2026-02-14Hunt Nimrata-301--
2026-02-14Hunt Nimrata-207--
2026-02-14Hunt Nimrata-204--
2026-02-14Hunt Nimrata-1,154$629.35$726,270
2026-02-14Hunt Nimrata+367--
2026-02-14Hunt Nimrata+1,508--
2026-02-14Hunt Nimrata+301--
2026-02-14Hunt Nimrata+207--
2026-02-14Hunt Nimrata+204--
2026-02-14Lane Michael-301--
2026-02-14Lane Michael-220--
2026-02-14Lane Michael-204--
2026-02-14Lane Michael-367--
2026-02-14Lane Michael-221$629.35$139,086
2026-02-14Lane Michael+367--
2026-02-14Lane Michael+301--
2026-02-14Lane Michael+220--
2026-02-14Lane Michael+204--
2026-02-14Underberg Sharon E.-265--
2026-02-14Underberg Sharon E.-218--
2026-02-14Underberg Sharon E.-176--
2026-02-14Underberg Sharon E.-173--
2026-02-14Underberg Sharon E.-251$629.35$157,967
2026-02-14Underberg Sharon E.+265--
2026-02-14Underberg Sharon E.+218--
2026-02-14Underberg Sharon E.+176--
2026-02-14Underberg Sharon E.+173--
2026-02-14Smith Martin Alexander-367--
2026-02-14Smith Martin Alexander-301--
2026-02-14Smith Martin Alexander-188--
2026-02-14Smith Martin Alexander-148--
2026-02-14Smith Martin Alexander-302$629.35$190,064
2026-02-14Smith Martin Alexander+367--
2026-02-14Smith Martin Alexander+301--
2026-02-14Smith Martin Alexander+188--
2026-02-14Smith Martin Alexander+148--
2026-02-14MAZELSKY JONATHAN JAY-1,099--
2026-02-14MAZELSKY JONATHAN JAY-958--
2026-02-14MAZELSKY JONATHAN JAY-915$629.35$575,855
2026-02-14MAZELSKY JONATHAN JAY+1,099--
2026-02-14MAZELSKY JONATHAN JAY+958--
2026-02-14FENNELL GEORGE-204--
2026-02-14FENNELL GEORGE-139--
2026-02-14FENNELL GEORGE-56--
2026-02-14FENNELL GEORGE-55--
2026-02-14FENNELL GEORGE-199$629.35$125,241
2026-02-14FENNELL GEORGE+204--
2026-02-14FENNELL GEORGE+139--
2026-02-14FENNELL GEORGE+56--
2026-02-14FENNELL GEORGE+55--
2026-02-12Erickson Michael G+162--
2026-02-12Erickson Michael G+13,667--
2026-02-12Emerson Andrew-65--
2026-02-12Emerson Andrew+284--
2026-02-12Emerson Andrew+729--
2026-02-12Emerson Andrew+162--
2026-02-12Emerson Andrew+4,270--
2026-02-12Erickson Michael G+1,580--
2026-02-12Erickson Michael G+4,739--
2026-02-12Schreck Michael+1,620--
2026-02-12Schreck Michael+1,094--
2026-02-12Schreck Michael+162--
2026-02-12Schreck Michael+4,625--
2026-02-12Johnson Michael Perkins+770--
2026-02-12Johnson Michael Perkins+162--
2026-02-12Johnson Michael Perkins+3,207--
2026-02-12Hunt Nimrata+1,620--
2026-02-12Hunt Nimrata+1,094--
2026-02-12Hunt Nimrata+162--
2026-02-12Hunt Nimrata+4,625--
2026-02-12Lane Michael+1,620--
2026-02-12Lane Michael+1,262--
2026-02-12Lane Michael+162--
2026-02-12Lane Michael+5,361--
2026-02-12Underberg Sharon E.+891--
2026-02-12Underberg Sharon E.+162--
2026-02-12Underberg Sharon E.+3,738--
2026-02-12Smith Martin Alexander+1,620--
2026-02-12Smith Martin Alexander+1,262--
2026-02-12Smith Martin Alexander+162--
2026-02-12Smith Martin Alexander+5,361--
2026-02-12MAZELSKY JONATHAN JAY+13,407--
2026-02-12FENNELL GEORGE+810--
2026-02-12FENNELL GEORGE+162--
2026-02-12FENNELL GEORGE+3,384--
2026-02-10FENNELL GEORGE-11,345--
2026-02-10FENNELL GEORGE-40$650.32$26,013
2026-02-10FENNELL GEORGE-2,809$649.2599$1,823,771
2026-02-10FENNELL GEORGE-966$648.7792$626,721
2026-02-10FENNELL GEORGE-1,060$647.2066$686,039
2026-02-10FENNELL GEORGE-2,782$646.2259$1,797,800
2026-02-10FENNELL GEORGE-2,161$645.2512$1,394,388
2026-02-10FENNELL GEORGE-397$644.016$255,674
2026-02-10FENNELL GEORGE-1,130$642.9974$726,587
2026-02-10FENNELL GEORGE+11,345$67.85$769,758
2026-02-09FENNELL GEORGE-1,476--
2026-02-09FENNELL GEORGE+1,476$67.85$100,147
2026-01-30HOOLEY JOSEPH L+36$670.46$24,137
2025-12-01Peacock Karen+231--
2025-12-01Peacock Karen+101--
2025-11-07Hunt Nimrata-5,405--
2025-11-07Hunt Nimrata-7,125--
2025-11-07Hunt Nimrata-1,378$705.5448$972,241
2025-11-07Hunt Nimrata-1,468$704.8659$1,034,743
2025-11-07Hunt Nimrata-1,465$703.7339$1,030,970
2025-11-07Hunt Nimrata-5,114$702.2017$3,591,059
2025-11-07Hunt Nimrata+5,405$505.53$2,732,390
2025-11-07Hunt Nimrata+7,125$288.78$2,057,557
2025-10-30HOOLEY JOSEPH L+39$628.54$24,513